Flexion Therapeutics (FLXN) – Analyst PT Change
-
Flexion Therapeutics (FLXN) PT Lowered to $10 at Northland Capital Markets
-
Credit Suisse Downgrades Flexion Therapeutics (FLXN) to Neutral
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FLXN Stock Lookup